KR101590858B1 - Enforced Antithrombosis activity, granule-type azuki bean powder containing Natural fruit juice and manufacturing Method thereof - Google Patents

Enforced Antithrombosis activity, granule-type azuki bean powder containing Natural fruit juice and manufacturing Method thereof Download PDF

Info

Publication number
KR101590858B1
KR101590858B1 KR1020140019506A KR20140019506A KR101590858B1 KR 101590858 B1 KR101590858 B1 KR 101590858B1 KR 1020140019506 A KR1020140019506 A KR 1020140019506A KR 20140019506 A KR20140019506 A KR 20140019506A KR 101590858 B1 KR101590858 B1 KR 101590858B1
Authority
KR
South Korea
Prior art keywords
red bean
bean powder
weight
juice
powder
Prior art date
Application number
KR1020140019506A
Other languages
Korean (ko)
Other versions
KR20150098351A (en
Inventor
조수환
이만효
손호용
이예슬
Original Assignee
조수환
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 조수환 filed Critical 조수환
Priority to KR1020140019506A priority Critical patent/KR101590858B1/en
Publication of KR20150098351A publication Critical patent/KR20150098351A/en
Application granted granted Critical
Publication of KR101590858B1 publication Critical patent/KR101590858B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L11/00Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/05Mashed or comminuted pulses or legumes; Products made therefrom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/02Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10Cereal-derived products
    • A23L7/198Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/60Sugars, e.g. mono-, di-, tri-, tetra-saccharides
    • A23V2250/64Sugar alcohols
    • A23V2250/6422Xylitol
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/10Drying, dehydrating
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/23Lactobacillus acidophilus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Agronomy & Crop Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 천연과즙 및 팥분말을 이용한 항혈전 활성 강화 과립형 팥분말 및 그 제조방법의 제공을 목적으로 하며, 삶은 팥 분말, 자일리톨, 유산균분말의 혼합물에 바나나과즙, 퀴위과즙 및 블루베리과즙을 배합하고 과립화 및 건조하는 것으로 이루어진다.
본 발명의 천연과즙 및 팥분말을 이용한 항혈전 활성 강화 과립형 팥분말은 가공함으로써 섭취가 간편한 특징이 있고 또 팥과 천연과즙의 영양성분의 조합 및 우수한 항혈전 활성에 의해 심혈관계, 뇌혈관계 질환의 예방 및 개선에 유용한 건강보조식품으로 제공하는 것이다.
The present invention provides an anti-thrombocyte activated granule type red bean powder using natural fruit juice and red bean powder and a method for preparing the same. The present invention also relates to a method for producing a granular red bean powder, which comprises a mixture of boiled red bean powder, xylitol and lactic acid bacterium powder, Followed by granulation and drying.
The granular red bean powder having enhanced anti-thrombogenic activity using the natural juice and red bean powder of the present invention is characterized by being easy to ingest by processing. Also, the combination of nutritional components of red bean and natural fruit juice and excellent antithrombotic activity are effective in preventing cardiovascular diseases, cerebrovascular diseases Which is useful for prevention and improvement of the health food.

Description

천연과즙 및 팥분말을 이용한 항혈전 활성 강화 과립형 팥분말 및 그 제조방법 {Enforced Antithrombosis activity, granule-type azuki bean powder containing Natural fruit juice and manufacturing Method thereof}[0001] The present invention relates to an anti-thrombocyte activated granule-type red bean powder using natural juice and red bean powder and a preparation method thereof,

본 발명은 천연과즙 및 팥분말을 이용한 항혈전 활성 강화 과립형 팥분말 및 그 제조방법에 관한 것이다.The present invention relates to granular red bean powder enhanced in antithrombotic activity using natural fruit juice and red bean powder, and a method for producing the same.

팥은 예로부터 중국, 한국, 일본 등 동양의 온대지방에서 주로 재배되어 온 콩과의 일년초 식물로서, 팥은 각기병에 좋은 식품으로 알려져 왔으며, 속이 열한 것과 소갈을 다스리는 식품으로 알려져 있으며, 명의별록에는 팥은 한열과 속이 열한 것을 다스리며 소명을 이롭게 하고 소갈에도 좋다고 되어있고, 약성본초에는 팥은 열독을 다스리고 악혈을 없애고 또 비와 위를 튼튼하게 해준다고 기록되어있다.Red bean is an annual plant of soybean which has been cultivated mainly in the temperate regions of East Asia such as China, Korea and Japan. Red bean has been known as a good food for each disease, It is said that the red bean regulates the fever and the twelfth, and it is said that it is beneficial to the calling and to the frog, and the red bean is in the weakly acidic herb, and it is said that it regulates the fever, eliminates the bloodsiness and strengthens the rain and stomach.

특히, 팥에는 비타민B1이 아주 많이 들어 있으므로 비타민B1의 부족과 관련된 식욕부진, 피로감, 수면장애, 기억력감퇴, 신경쇠약 등의 증세 및 질병의 예방과 퇴치에 유용하며, 신경을 많이 쓰는 정신근로자나 수험생 등에게 좋은 식품이며 또 신장병, 당뇨병 등에도 유효하다.Especially, because red bean contains a lot of vitamin B1, it is useful for prevention and elimination of symptoms such as anorexia, fatigue, sleeping disorder, memory loss, nervous breakdown and diseases associated with the lack of vitamin B1, It is a good food for examinees and is also effective for kidney disease, diabetes and the like.

최근 민간요법이나 논문 등에 의해 팥의 기능이 밝혀지면서 새로운 well-being 제품으로 서서히 두각을 나타내고 있어, 향후 그 판매량이 증가할 것으로 기대되지만 가공 공정상의 어려움으로 인하여 다양한 제품으로 출시되지 못하고 있으므로 대중적으로 큰 호응을 유도하지는 못하고 있다.As the function of red beans has recently been revealed by folk remedies and papers, it is gradually emerging as a new well-being product, and it is expected that the sales volume will increase in the future. However, due to difficulties in processing, It does not induce a response.

일반적으로 팥은 잡곡밥, 팥죽, 빵류 등에 사용하는 팥앙금(팥소), 양갱 등에 주로 이용되고 있으며, 건강식품 및 의약과 관련한 선행기술로 예를 들면, 국내 등록특허공보 등록번호 10-1067611호에 건강식품으로 팥을 삶은 물에 양조식초를 첨가하고, 검은콩을 혼합한 슬러리 상태의 분쇄물에 1 ~ 2중량%로 팥앙금을 첨가 혼합하여 가열 살균처리한 다음 용기에 충전하는 팥 음료의 제조방법을 개시하고 있고, 국내특허공보 등록번호 10-1166698호에는 좀돌팥(Vigna nakashimae)의 종실을 분쇄하여 종실무게 10 ~ 20배의 50 ~ 100% 에탄올 수용액으로 20 ~ 30℃에서 교반하여 추출하는 단계, 상기 추출액을 원심분리하여 상등액 만을 회수하는 단계 및 상기 액을 감압 농축 및 동결건조시켜 연갈색 또는 갈색의 분말을 제조하는 단계를 포함하는 알파-글루코시데이즈 억제 효과를 갖는 좀돌팥 추출물의 제조방법 및 당뇨병 또는 비만의 예방 및 치료용 조성물을 개시하고 있으며, 국내 등록특허공보 등록번호 10-1001705호에는 팥 0.87 내지 8.7 중량부, 흑태 0.355 내지 3.55 중량부, 할맥 6.705 내지 67.05 중량부, 찰보리쌀 1.315 내지 13.15 중량부, 현미 5.735 내지 57.35중량부, 찹쌀 8.96 내지 89.6 중량부 및 찰흑미 3.735 내지 37.35 중량부를 포함하여 이루어지는 비만, 고지혈증 및 당뇨의 예방 및 개선용 조성물을 개시하고 있으며, 또 국내 등록특허공보 등록번호 10-1249795호에는 홍국균을 포함하는 고체 종균으로 팥을 발효시켜 얻은 산물이고 발효에 의해 발효 전보다 향상된 항산화 활성및 콜레스테롤 저하 활성을 나타내는 발효 팥으로서, 상기 고체 종균은 고체 배지인 밀 기울 또는 쌀겨에 모나스커스 필로서스(Monascus pilosus) 홍국균 또는 이를 포함하는 종균용 배양액을 접종하고 배양하여 수득한 것을 특징으로 하는 발효 팥 및 항산화용 조성물을 개시하고 있다.Generally, red beans are mainly used in bean jam (bean jam), rice bran, etc. used for rice, rice porridge, and bakery products. Prior art related to health foods and medicines include, for example, Korean Patent Registration No. 10-1067611, Discloses a process for preparing red bean beverages in which brewed vinegar is added to boiled water, black beans are mixed with 1 to 2 wt% of bean jam in a slurry state mixed with the black beans, , And Korean Patent Publication No. 10-1166698 discloses a method of pulverizing seeds of Vigna nakashimae and extracting it by stirring at 20 to 30 ° C in an aqueous 50 to 100% ethanol solution having a seed weight of 10 to 20 times, Centrifuging the extract to recover only the supernatant, and concentrating the supernatant and lyophilizing the solution to prepare a light brown or brown powder. The alpha-glucosidase inhibitory effect And a composition for prevention and treatment of diabetes or obesity is disclosed in Korean Patent Registration No. 10-1001705. The composition includes 0.87 to 8.7 parts by weight of red bean, 0.355 to 3.55 parts by weight of black bean, Discloses a composition for prevention and improvement of obesity, hyperlipidemia and diabetes, which comprises 67.05 parts by weight of pearl rice, 1.315 to 13.15 parts by weight of pearl rice, 5.735 to 57.35 parts by weight of brown rice, 8.96 to 89.6 parts by weight of glutinous rice, and 3.735 to 37.35 parts by weight of black rice In addition, Korean Registered Patent Publication No. 10-1249795 discloses a fermented red bean which is a product obtained by fermenting red beans with a solid germ including red ginseng root and exhibiting an antioxidative activity and a cholesterol lowering activity improved by fermentation before fermentation, Monascus pilosus in wheat or rice bran, solid medium, A seed culture comprising inoculation and the culture to initiate the fermentation and the beans antioxidant composition, wherein the resultant.

본 발명은 상기한 선행기술에 비하여 제조공정이 간단하고, 영양소 및 기능성과 함께 항혈전 활성이 강화된 천연과즙 및 팥을 주재로 한 과립형 건강보조식품을 제조함으로써 본 발명을 완성하였다.The present invention has been accomplished by preparing granular health supplements based on natural juice and red bean having a simple manufacturing process, enhanced nutritional and functional properties, and enhanced antithrombotic activity as compared with the prior art described above.

본 발명은 천연과즙 및 팥분말을 이용하여 항혈전 활성이 강화된 과립형 팥분말을 제조하는 방법의 제공을 목적으로 하며, 구체적으로는 팥은 저장성이 좋으나, 가공을 위해 삶을 경우 최대한 빨리 섭취해야 하는 결점을 개선하고 섭취가 간편하고, 영양소 및 기능성을 개선하여 항혈전 활성이 강화된 천연과즙 및 팥분말을 이용한 과립형 팥분말의 제조방법 및 그 제조방법에 의해 제조된 항혈전 활성이 강화된 과립형 팥분말로 이루어진 건강식품의 제공을 목적으로 하는 것이다.The present invention aims to provide a method for preparing granular red bean powder having enhanced antithrombotic activity by using natural juice and red bean powder. Specifically, red bean is good in storage property, but when taken for processing, A method for preparing granular red bean powder using natural juice and red bean powder with improved antioxidant activity by improving deficiencies and improving nutrients and functionalities and improving the antithrombotic activity produced by the method The present invention also provides a health food comprising the granular red bean powder.

본 발명의 목적을 달성하기 위한 과제의 해결수단으로 천연과즙 및 팥분말을 이용한 항혈전 활성 강화 과립형 팥분말의 제조방법은 a) 삶은 팥분말 100중량부에 대하여 자일리톨 15 ~ 20중량부, 유산균분말 10 ~ 15중량부를 혼합하여 1차 혼합물을 얻는 제1단계와, b) 1차 혼합물 100중량부에 대하여 바나나과즙, 키위과즙 및 블루베리과즙이 중량비로 1:2:1로 혼합된 천연과즙 100 내지 150 중량부를 배합하여 2차 혼합물을 얻는 제2단계 및 c) 2차 혼합물을 과립화하고 건조 및 포장하는 제3단계를 포함하는 것으로 이루어진다.A method for producing an anti-thrombocyte activated granule-type red bean powder using natural juice and red bean powder comprises the steps of: a) mixing 15 to 20 parts by weight of xylitol, 100 parts by weight of lactic acid bacteria A first step of mixing 10 to 15 parts by weight of the powder to obtain a first mixture; b) mixing 100 parts by weight of the first mixture with a mixture of banana juice, kiwifruit juice and blueberry juice in a weight ratio of 1: 2: 100 to 150 parts by weight to obtain a second mixture, and c) granulating the second mixture, drying and packaging.

본 발명의 또 다른 목적달성을 위한 해결수단으로 천연과즙 및 팥분말을 이용한 항혈전 활성 강화 과립형 팥분말로 이루어진 건강식품은 상기한 본 발명의 제1단계 내지 제4단계에 의해 제조된 과립형 팥분말을 포함하는 것으로 이루어진다.As a solution for achieving still another object of the present invention, a health food made of granular red bean powder enhanced in antithrombotic activity using natural fruit juice and red bean powder is prepared by mixing granular And red bean powder.

본 발명에 따른 상기 제1단계의 삶은 팥분말은 팥을 삶는 일반적인 방법에 따라 정선된 팥을 물에 불린(수침) 후, 물과 함께 팥이 충분히 익을 때까지 삶은 다음, 삶은 팥을 건조를 위하여 조분쇄하고, -80℃ ~ -30℃의 조건에서 함수율 2%로 동결건조한 후, 온도를 30℃까지 서서히 올려 건조된 삶은 팥을 분쇄기에서120 ~ 150메쉬로 분쇄하여 삶은 팥분말을 제조하는 것으로 이루어진다.The first stage boiled red bean powder according to the present invention is prepared by boiling the selected red beans in water according to the general method of boiling the red beans, boiling them with water until the beans are fully ripe, and then drying the boiled red beans Dried and lyophilized at a water content of 2% at a temperature of -80 ° C to -30 ° C and then gradually heated to 30 ° C to pulverize the dried boiled red beans in a grinder at 120-150 mesh to produce boiled red bean powder .

또는, 깨끗하게 세척한 팥을 50 ~ 80℃에서 3 ~ 5시간 볶은 후, 물과 함께 팥이 충분히 익을 때까지 삶은 다음, 삶은 팥을 상기한 방법으로 동결건조하여 얻어진 건조된 삶은 팥을 분쇄기에서 120 ~ 150메쉬로 분쇄하여 삶은 팥분말을 제조하는 것으로 이루어진다.Alternatively, the cleaned red beans are roasted at 50 to 80 ° C for 3 to 5 hours, then boiled with water until the red beans are sufficiently cooked, and then boiled red beans are lyophilized by the method described above. To 150 mesh to produce boiled red bean powder.

팥은 당질 54%, 사포닌(saponin) 0.3% 함유되어 있으며, 단백질은 21% 함유하며, 그 중 약 80%가 글로부린(globulin)이며, 지방은 적으나, 약 24%의 연지질이 함유되어 있는 것으로 밝혀져 있다. 상기 본 발명에 따른 동결건조한 삶은 팥분말은 100g당 356Kcal를 나타나며, 주요 영양성분의 함량을 아래 [표1] 및 [표2]에 나타내었다.The red bean contained 54% of carbohydrate and 0.3% of saponin. It contained 21% of protein, about 80% of which was globulin and the fat was low, but about 24% . The freeze-dried boiled red bean powder according to the present invention exhibits 356 Kcal per 100 g, and the contents of major nutrients are shown in [Table 1] and [Table 2] below.

영양성분nutrient 수분moisture 단백질protein 지방Fat 탄수화물carbohydrate 함량(g/100g)Content (g / 100g) 8.98.9 19.319.3 0.10.1 68.468.4

영양성분nutrient 총 식이섬유Total dietary fiber 불용성식이섬유Insoluble fiber 수용성 식이섬유Soluble fiber 화분Flowerpot 함량(g/100g)Content (g / 100g) 12.212.2 11.811.8 0.40.4 3.33.3

또 본 발명에 따른 제1단계의 유산균분말은 락토바실러스 액시도필러스, 락토바실러스 불가리쿠스, 락토바실러스 프랜타럼, 비피도박테리움 비피덤, 비피도박테리움 락티스 등으로부터 선택되는 1 이상의 유산균분말로 이루어지며, 이러한 유산균분말은 시판되고 있으며, 예를 들면, (주)비전바이오캠사, 상품명 LLB 혼합유산균 509로 시판되며, 자일리톨 역시 널리 시판되고 있는 것을 사용하는 것으로 이루어진다.The first stage lactic acid bacteria powder according to the present invention may further comprise at least one lactobacillus powder selected from the group consisting of Lactobacillus acidophilus, Lactobacillus bulgaricus, Lactobacillus frantarium, Bifidobacterium bifidum, Bifidobacterium lactis, These lactic acid bacteria powders are commercially available. For example, they are commercially available under the trade names Vision BioCampus, LLB mixed lactic acid bacteria 509, and xylitol, which are widely available.

상기 본 발명의 제2단계에 따른 바나나, 키위 및 블루베리에는 당, 식물섬유, 비타민 및 칼슘, 철분, 망간 등의 무기성분이 함유되어 있으므로 팥과 조합하여 팥에 부족한 영양성분을 조합하는 것으로 이루어지며, 시판하고 있는 바나나, 키위 및 블루베리를 이용하여 각각 믹서기로 분쇄하여 슬러리 상태로 하여 배합하거나 키위 및 블루베리를 함께 믹서기에 투입하고 분쇄하여 슬러리 상태로 하여 배합하는 것으로 이루어진다.Since the banana, kiwi and blueberry according to the second step of the present invention contain sugar, vegetable fiber, vitamins, and inorganic components such as calcium, iron, and manganese, they are combined with red bean And the mixture is pulverized with a mixer using a commercially available banana, kiwi and blueberry to form a slurry state, or the kiwi and blueberry are put into a mixer together and pulverized to prepare a slurry.

상기 바나나과즙, 키위과즙 및 블루베리과즙인 천연과즙의 배합은 상기 제1단계의 1차 혼합물과 교반하면서 균일하게 혼합하여 후속하는 제3단계에서 과립화가 잘 수행될 수 있는 반죽상태의 2차 혼합물을 얻는 것으로 이루어진다.The combination of the banana juice, the kiwifruit juice and the natural juice, which is the blueberry juice, is uniformly mixed while stirring with the first mixture of the first step, so that the second mixture in the kneading state which can be well granulated in the subsequent third step .

상기 본 발명의 반죽상태의 2차 혼합물의 과립화는 널리 알려진 과립제조기를 이용하여 과립으로 제조하며, 제조된 과립형 팥분말은 일반적으로 알려진 열풍건조기에 의해 열풍으로 건조한 후 포장하는 것으로 이루어진다. The granulation of the dough-state secondary mixture of the present invention is made into granules using a well-known granulating machine, and the granular red bean powder thus prepared is dried by hot air using a generally known hot air drier and then packed.

상기 본 발명의 제1단계 내지 제3단계로부터 제조된 과립형 팥분말은 동결건조한 삶은 팥의 경우 최대한 빨리 섭취해야 하는 결점을 개선하여, 과립형으로 가공함으로써 섭취가 간편하고, 팥에 천연과즙의 첨가에 의해 영양분 및 기호성이 개선되어 건강보조식품으로 유용하게 제공된다.The granular red bean powder prepared from the first step to the third step of the present invention improves deficiencies that should be taken as soon as possible in case of lyophilized boiled red beans and is processed into a granular form so that it is easy to ingest. The nutritional and palatability is improved by the addition, and it is usefully provided as a health supplement.

또한 일반적인 팥의 항당뇨 특성과 함께 본 발명에 따른 과립형 팥분말의 우수한 항혈전 활성으로 본 발명에 따른 과립형 팥분말은 심혈관계, 뇌혈관계 질환의 예방 및 개선에 유용한 건강보조식품 또는 의약 등으로 제공되는 것이 가능하다.In addition, the granular red bean powder according to the present invention has excellent antithrombotic activity of the granular red bean powder according to the present invention together with the general anti-diabetic characteristic of red bean of the present invention, and the granular red bean powder according to the present invention is useful as a health supplement or medicament useful for prevention and improvement of cardiovascular diseases and cerebrovascular diseases . ≪ / RTI >

본 발명의 천연과즙과 삶은 팥분말을 이용한 항혈전 활성 강화 과립형 팥분말은 동결건조한 삶은 팥분말을 과립으로 가공함으로써 삶은 팥의 경우 최대한 빨리 섭취해야 하는 결점을 개선함과 동시에 섭취가 간편한 특징이 있고 또 본 발명의 과립형 팥분말은 팥과 천연과즙의 영양성분의 조합 및 우수한 항혈전 활성을 나타내므로 일반적인 팥의 항당뇨 특성과 함께 심혈관계, 뇌혈관계 질환의 예방 및 개선에 유용한 건강보조식품으로 제공되는 특징을 지니고 있다.The anti-thrombocyte activated granule type red bean powder using the natural juice and boiled red bean powder of the present invention is characterized by processing the freeze-dried boiled red bean powder into granules, thereby improving deficiencies in the case of boiled red beans as soon as possible and at the same time, In addition, the granular red bean powder of the present invention exhibits a combination of nutritional components of red bean and natural fruit juice and exhibits excellent antithrombotic activity. Therefore, it is possible to provide a health supplement which is useful for prevention and improvement of cardiovascular and cerebrovascular diseases, As shown in FIG.

아래에서는 실시예(제조예) 및 시험예를 통하여 본 발명에 따른 천연과즙 및 팥분말을 이용한 항혈전 활성이 강화된 과립형 팥분말 및 그 제조방법에 대하여 보다 구체적으로 설명하지만 아래 기재에 의해 본 발명이 한정되는 것은 아니다.Hereinafter, the granular red bean powder enhanced in antithrombotic activity using the natural juice and red bean powder according to the present invention and the preparation method thereof will be described in more detail through Examples (Preparation Examples) and Test Examples, The invention is not limited thereto.

<실시예><Examples>

a). 삶은 팥분말 및 1차 혼합물 제조a). Manufacture of boiled bean powder and primary mixture

정선된 팥을 70℃ 조건에서 4시간 볶은 팥 100중량부에 대하여 물 150중량부 및 소량의 소금을 투입하고, 100℃ 조건에서 8시간 정도 끓이면서 팥을 충분히 익힌 다음, 삶은 팥을 미리 조분쇄하여 동결건조기에서 -45℃ 조건으로 4일간 건조시켜 함수율 2%의 동결건조하고, 얻어진 건조된 삶은 팥을 분쇄기로 150메쉬로 분쇄하여 삶은 팥분말을 제조하였다.150 parts by weight of water and a small amount of salt were added to 100 parts by weight of red bean roasted at 70 ° C for 4 hours and boiled for about 8 hours at 100 ° C to sufficiently cook red beans. Dried in a freeze dryer at -45 ° C for 4 days, and then dried at a moisture content of 2%. The resulting dried boiled red beans were pulverized with a grinder to a 150 mesh to produce boiled red bean powder.

상기 삶은 팥분말 100중량부에 대하여 자일리톨 20중량부 및 유산균분말(시판제품인(주)비전바이오캠사, 상품명 LLB 혼합유산균 509 사용) 15중량부의 비율로 교반기가 장착된 혼합기에 투입하고 균일하게 혼합하여 1차혼합물을 얻었다.20 parts by weight of xylitol and 15 parts by weight of a lactic acid bacterium powder (commercially available from Vision BioCampa Co., Ltd., trade name: LLB mixed lactic acid bacteria 509) were added to 100 parts by weight of the above boiled bean powder and mixed in a mixer equipped with a stirrer. A primary mixture was obtained.

b). 팥분말과 천연과즙의 혼합물 제조(2차 혼합물 제조)b). Preparation of a mixture of red bean powder and natural fruit juice (preparation of second mixture)

껍질을 제거한 바나나 및 키위, 블루베리를 중량비로 1 : 2 : 1의 비율이 되게 믹서기에 함께 투입하여 분쇄하여 슬러리 상태의 천연과즙을 얻었다.The peeled banana, kiwi, and blueberry were added together in a mixer at a weight ratio of 1: 2: 1, followed by pulverization to obtain a natural juice in a slurry state.

교반기가 장차가 된 배합기(반죽기)에 상기에서 제조한 1차 혼합물 100중량부에 대하여 상기 슬러리 상태의 천연과즙 100중량부를 천천히 투입하면서 1차 혼합물과 천연과즙이 골고루 배합되어 반죽상태가 되도록 하여 2차 혼합물을 얻었다.100 parts by weight of the slurry-like natural fruit juice was slowly added to 100 parts by weight of the primary mixture prepared in the above-mentioned mixer (kneader) in which the stirrer was introduced, so that the primary mixture and the natural fruit juice were uniformly mixed, Tea mixture.

c). 과립제조 및 건조(최종목적물)c). Granulation and drying (final object)

상기에서 제조한 반죽상태의 2차 혼합물을 과립제조기에 넣고 과립으로 한 다음, 열풍건조기에 넣고, 50℃에서 24시간 건조하여 건조된 팥과립을 제조하였다.The kneaded secondary mixture prepared above was placed in a granulator and granulated. The granules were then placed in a hot-air dryer and dried at 50 ° C for 24 hours to prepare dried bean granules.

<시험예 1>&Lt; Test Example 1 >

상기 실시예에서 제조한 팥과립은 pH 4.09, 당도 80(Brix)를 나타내는 것을 확인할 수 있었으며, 이러한 본 발명의 팥과립은 일반적인 팥가루가 통상 pH 6.15, 당도 40(Brix)를 나타내는데 비하여, pH는 낮고, 당도가 높게 나타났으며, 이는 자일리톨 및 천연과즙의 유기산의 첨가에 기인하는 것으로 예측된다.The red bean granules prepared in the above example exhibited a pH of 4.09 and a sugar content of 80 (Brix). The red bean flour of the present invention generally showed a pH of 6.15 and a sugar content of 40 (Brix) And high sugar content, which is predicted to be due to the addition of organic acids of xylitol and natural fruit juice.

그리고 상기 실시예에서 제조한 팥과립에 대하여, 조직감, 향기, 기호성에 관한 관능평가를 위해 성인남녀 각 10명씩을 대상으로 하여 평가하고 그 결과를 아래 [표 3]에 나타내었다(평가방법은 10(아주좋음) ~ 0(아주나쁨)으로 실시하고 평균점수로 나타내었다).For the sensory evaluation on texture, flavor and palatability of the red bean granules prepared in the above example, each adult male and female was evaluated for each 10 persons, and the results are shown in Table 3 below (the evaluation method is 10 (Very good) ~ 0 (very bad) and expressed as average score.

구분division flavor 향기Scent 식감Texture 기호성Purity 종합Synthesis south 77 66 77 77 6.86.8 female 66 66 66 77 6.36.3

<시험예 2>&Lt; Test Example 2 &

상기 실시예에서 제조한 팥분말 및 팥과립에 대한 에탄올 추출효율 및 성분을 비교하고, 그 결과를 아래 [표 4]에 나타내었으며, 추출방법은 각각의 시료에 10배 Volume으로 95% Ethanol을 첨가하여 2회 추출하였다.The ethanol extraction efficiency and components of the red bean powder and red bean granules prepared in the above examples were compared and the results are shown in Table 4 below. The extraction method was as follows: 95% Ethanol was added to each sample 10 times in volume And extracted twice.

또한 Hexene분획 , Ethyl acetate 분획 , Butanol 분획 및 물 잔류물의 분획효율을 분석하고, 그 결과를 아래 [표 5]에 나타내었다.The fractions of Hexene fraction, Ethyl acetate fraction, Butanol fraction and Water residue were analyzed, and the results are shown in Table 5 below.

시료명Name of sample 에탄올 추출효율(%)Ethanol extraction efficiency (%) 합계(%)Sum(%) 1자 추출1 character extraction 2차 추출Secondary extraction 팥분말Red bean powder 1.481.48 0.350.35 1.831.83 팥과립Red bean granules 13.813.8 6.356.35 20.1520.15

상기 [표 4]에 의하면, 팥분말는 1차와 2차 추출을 통해 1.83%의 에탄올 추출 효율을 보이고 있으며, 이에 비해 팥과립의 에탄올 추출효율은 20.15%를 나타내고 있는 점으로 미루어 본 발명에 따른 팥과립이 팥분말에 비해 약 11배 이상 높은 지용성 성분을 가지고 있음을 알 수 있으며, 아래 [표 5]에 의하면, 팥분말에서 15%가 Hexene 분획물인데 비하여, 팥과립의 경우 대부분(87%)이 헥센분획물로 이행된 점을 미루어 팥의 경우 헥센추출성 물질이 0.27g/팥 100g 인데 비해, 팥과립의 경우 헥센 추출성 물질이 17.4g/팥과립 100g 인 것을 확인할 수가 있다.According to the above Table 4, the extraction efficiency of 1.83% of red bean powder by primary and secondary extraction is 20.15% compared with that of red bean powder, As shown in Table 5 below, 15% of Hexene fraction is in the red bean powder compared to that of red bean powder, whereas most of the red bean powder is 87% In the case of red bean, the content of hexene extractable material is 0.27 g / red bean 100 g, whereas that of red bean granule is 17.4 g / red bean granule 100 g.

Solvent FractionSolvent Fraction 분획효율(%)Fraction efficiency (%) 팥분말Red bean powder 팥과립Red bean granules Hexene Fraction Hexene Fraction 14.6914.69 87.0487.04 Ethyl acetate FractionEthyl acetate Fraction 1.381.38 0.40.4 ButanolFraction ButanolFraction 19.6319.63 0.40.4 Water residueWater residue 63.7163.71 10.9310.93

<시험예 3>&Lt; Test Example 3 >

상기 실시예에서 제조한 팥가루 및 팥과립의 에탄올 추출물과 Hexene 분획, Ethyl acetate 분획, Butanol 분회 및 물 잔류물에 대하여 총 당과 환원당, 총 폴리페놀 및 총 플라보노이드에 대한 성분을 분석하고 그 결과를 아래 [표 6]에 나타내었다.The components of total sugar and reducing sugar, total polyphenol and total flavonoid were analyzed for the ethanol extracts of red bean flour and red bean flour, Hexene fraction, Ethyl acetate fraction, Butanol fraction and water residues prepared in the above Examples, Are shown in Table 6 below.

1). 총 당 및 환원당 정량One). Quantity of total sugar and reducing sugar

환원당은 DNS법으로 정량하고, 총당은 phenol-sulfuric acid법을 이용하여 정량하였으며, 자세하게는 환원당 분석은 Dinitrosalicylic acid(DNS)법을 응용하여 전 처리된 시료에 25% HCl을 넣고 60℃에서 30분간 가수분해한 뒤 다시 8N NaOH로 중화하고 여기에 DNS시약을 넣어 반응시킨 후, 550nm에서 흡광도를 측정하였다. Reducing sugar was quantitated by DNS method and total sugar was quantified by phenol-sulfuric acid method. Specifically, 25% HCl was added to pretreated sample using dinitrosalicylic acid (DNS) method for reducing sugar analysis. After hydrolysis, it was neutralized with 8N NaOH, reacted with a DNS reagent, and absorbance was measured at 550 nm.

2)총 폴리페놀 정량2) Total polyphenol content

팥분말 및 팥과립의 총 polyphenol 함량은 추출 검액 400㎕에 50㎕의 Folin-ciocalteau, 100㎕의 Na2CO3포화용액을 넣고 실온에서 1시간 방치한 후 725 nm에서 흡광도를 측정하였다. 표준시약으로는 tannic acid를 사용하였다. Total polyphenol contents of red bean powder and red bean granules were measured by adding 50 μl of Folin-ciocalteau and 100 μl of Na 2 CO 3 saturated solution to 400 μl of the extract solution, leaving the solution at room temperature for 1 hour, and then measuring the absorbance at 725 nm. Tannic acid was used as a standard reagent.

3)총 플라보노이드 정량3) Quantification of total flavonoids

팥분말 및 팥과립의 총 flavonoid의 함량 측정은 각각의 시료를 18시간 메탄올 교반 추출하고 여과한 추출 검액 400㎕에 90% diethylene glycol 4㎖를 첨가하고 다시 1N NaOH 40㎕를 넣고 37℃에서 1시간 반응 후 420nm에서 흡광도를 측정하였다. 표준시약으로는 rutin을 사용하였다. To measure the total flavonoid content in red bean powder and red bean granules, each sample was stirred for 18 hours in methanol, and 4 ml of 90% diethylene glycol was added to 400 μl of the filtered extract. 40 μl of 1N NaOH was added thereto, Absorbance was measured at 420 nm after the reaction. As a standard reagent, rutin was used.



시료


sample

추출 및 분획효율
(%)

Extraction and fractionation efficiency
(%)
Contents(mg/g-extract)Contents (mg / g-extract)
TF
(Rutin Eq.)
TF
(Routine Eq.)
TP
(Tannic acid
Eq.)
TP
(Tannic acid
Eq.)
TS
(Sucrose Eq.)
TS
(Sucrose Eq.)
RS
(Glucose Eq.)
RS
(Glucose Eq.)




red bean
minute
Words
EtOH ex.EtOH ex. 1.81.8 2.0± 0.12.0 ± 0.1 19.0± 0.319.0 ± 0.3 38.0± 0.938.0 ± 0.9 15.2± 0.615.2 ± 0.6
Hex frHex fr 14.714.7 1.5± 0.21.5 ± 0.2 13.0± 0.713.0 ± 0.7 14.3± 0.314.3 ± 0.3 10.7± 1.010.7 ± 1.0 EA fr.EA fr. 1.41.4 7.6± 0.57.6 ± 0.5 47.4± 5.647.4 ± 5.6 28.7± 0.728.7 ± 0.7 22.2± 1.822.2 ± 1.8 B fr.B fr. 19.619.6 6.3± 0.16.3 ± 0.1 36.4± 1.736.4 ± 1.7 58.8± 0.058.8 ± 0.0 33.1± 0.633.1 ± 0.6 W resW res 63.763.7 1.1± 1.01.1 ± 1.0 11.1± 1.111.1 ± 1.1 81.5± 0.081.5 ± 0.0 58.2± 0.158.2 ± 0.1



red bean
and
Lip
EtOH ex.EtOH ex. 20.220.2 0.1± 0.10.1 ± 0.1 10.6± 0.910.6 ± 0.9 127.3± 2.9127.3 ± 2.9 117.2± 1.0117.2 ± 1.0
Hex frHex fr 87.087.0 4.0± 1.24.0 ± 1.2 11.8± 1.811.8 ± 1.8 31.4± 0.331.4 ± 0.3 24.4± 1.324.4 ± 1.3 EA fr.EA fr. 0.40.4 22.4± 3.922.4 ± 3.9 57.3± 1.157.3 ± 1.1 109.4± 2.2109.4 ± 2.2 73.7± 2.773.7 ± 2.7 B fr.B fr. 0.40.4 0.7± 0.10.7 ± 0.1 18.1± 0.118.1 ± 0.1 179.9± 1.0179.9 ± 1.0 155.8± 1.0155.8 ± 1.0 W resW res 10.910.9 1.7± 1.61.7 ± 1.6 1.6± 0.11.6 ± 0.1 195.0± 1.5195.0 ± 1.5 171.9± 1.0171.9 ± 1.0

상기 [표 6]에 의하면, 팥분말 및 팥과립 에탄올 추출물을 비교해 보았을 때, 총 폴리페놀 함량은 팥가루에서 2배 정도 높게 나타났으나, 반면 총 당의 경우에는 팥 과립에서 3배 높게 나타났으며, 또한 환원당의 경우 팥과립이 팥분말 보다 약 7.7배 높은 함량을 나타내어 팥과립 추출물이 상대적으로 많은 양의 당질을 포함하고 있음을 확인할 수 있었다.According to the above Table 6, when the ethanol extracts of red bean powder and red bean powder were compared, the total polyphenol content was about twice as high as that of red bean powder, whereas that of total sugar was three times as high as that of red bean powder , And in the case of reducing sugar, the content of red bean granules was about 7.7 times higher than that of red bean powder, indicating that the red bean granule extract contained a relatively large amount of saccharides.

그리고 순차적 유기용매 분획물의 경우, 총 폴리페놀 함량은 팥분말 및 팥과립 에서 모두 에틸아세테이트 분획 > 부탄올 분획 > 헥센 분획 > 물 잔류물 순으로 나타났으나, 총 플라보노이드 함량은 팥분말의 경우, 에틸아세테이트 분획 > 부탄올 분획 > 헥센 분획 > 물 잔류물 순으로, 팥 과립의 경우 에틸아세테이트 분획 > 헥센 분획 > 물 잔류물 > 부탄올 분획 순으로 나타났다. In the case of sequential organic solvent fractions, the total polyphenol contents were in the order of ethyl acetate fraction, butanol fraction, hexene fraction and water residue in the red bean powder and red bean powder, respectively. The total flavonoid content, however, The fractions were in the order of ethyl acetate fraction, hexane fraction, water residue, and butanol fraction in the order of fraction> butanol fraction> hexene fraction> water residue.

<시험예 4><Test Example 4>

상기 팥분말 및 팥과립의 에탄올 추출물과 Hexene 분획, Ethyl acetate 분획, Butanol 분획 및 물 잔류물에 대한 항혈전 활성평가를 하고, 그 결과를 아래 [표7]에 나타내었다. 항혈전 활성평가는 기존에 보고된 방법에 준해 평가하였으며(Sohn et al., 2004. Kor. J. Pharmacogn 35. 52-61; Kwon et al., 2004. J. Life Science, 14. 509-513; 류 등 2010. J. Life Science, 20. 922-928), 트롬빈 타임, 프로트롬빈 타임과 에이피티 타임을 측정하였다. 혈장은 표준혈장(MD Pacific Co., China)을 구입하여 사용하였으며, 기타 시약은 씨그마사(Sigma Co., USA)의 제품을 구입하여 사용하였다. 트롬빈 타임, 프로트롬빈 타임과 에이피티 측정법은 다음과 같은 과정으로 수행되었다.The antithrombotic activity of the ethanol extract of red bean powder and red bean granules, Hexene fraction, Ethyl acetate fraction, Butanol fraction and water residue was evaluated, and the results are shown in Table 7 below. Evaluation of antithrombotic activity was evaluated in accordance with previously reported methods (Sohn et al., 2004. Kor J. Pharmacogn 35, 52-61; Kwon et al., 2004. J. Life Science, 14. 509-513 ; 2010. J. Life Science, 20. 922-928), thrombin time, prothrombin time and apathy time were measured. Plasma was purchased from standard plasma (MD Pacific Co., China) and other reagents were purchased from Sigma Co., USA. The thrombin time, prothrombin time, and apathy measurements were performed as follows.

a). 트롬빈 타임(Thrombin Time)a). Thrombin Time

37℃에서 0.5U 트롬빈 (Sigma Co., USA) 50㎕와 20mM CaCl2 50㎕, 다양한 농도의 시료 추출액 10㎕를 Amelung coagulometer KC-1A(Japan)의 튜브에 혼합하여 2분간 반응시킨 후, 혈장 100㎕를 첨가한 후, 혈장이 응고될 때까지의 시간을 측정하였다. 대조로는 아스피린(Sigma Co., USA)을 사용하였으며, 용매 대조구로는 시료 대신 DMSO를 사용하였다. DMSO의 경우 32.1초의 응고시간을 나타내었다. 0.5U thrombin in 37 ℃ (Sigma Co., USA) 50㎕ with 20mM CaCl 2 And 10 μl of sample extracts at various concentrations were mixed in a tube of Amelung coagulometer KC-1A (Japan) and reacted for 2 minutes. Then, 100 μl of plasma was added, and the time until the plasma was solidified was measured. As a control, aspirin (Sigma Co., USA) was used and DMSO was used as a solvent control instead of the sample. DMSO showed a clotting time of 32.1 sec.

트롬빈 저해 효과는 3회 이상 반복한 실험의 평균치로 나타내었으며, 시료 첨가 시의 응고시간을 용매 대조구의 응고시간으로 나눈 값으로 나타내었다.The thrombin inhibitory effect was expressed as the average value of the experiments repeated three times or more, and the coagulation time at the time of adding the sample was divided by the coagulation time of the solvent control.

b). 프로트롬빈 타임(prothrombin time)b). Prothrombin time

표준혈장(MD Pacific Co., China) 70㎕와 다양한 농도의 시료액 10㎕를 Amelung coagulometer KC-1A(Japan)의 튜브에 첨가하여 37℃에서 3분간 가온 후, 130㎕의 PT reagent를 첨가하고 혈장이 응고될 때까지의 시간을 3회 반복한 실험의 평균치로 나타내었다. 대조로는 아스피린(Sigma Co., USA)을 사용하였으며, 용매 대조구로는 시료 대신 DMSO를 사용하였다. DMSO의 경우 18.1초의 응고시간을 나타내었다.70 μl of standard plasma (MD Pacific Co., China) and 10 μl of various concentrations of sample were added to a tube of Amelung coagulometer KC-1A (Japan), and the mixture was heated at 37 ° C. for 3 minutes. Then, 130 μl of PT reagent was added The time until the plasma coagulated was expressed as the average value of the experiment which was repeated three times. As a control, aspirin (Sigma Co., USA) was used and DMSO was used as a solvent control instead of the sample. DMSO showed a clotting time of 18.1 sec.

프로트롬빈 저해 효과는 3회 이상 반복한 실험의 평균치로 나타내었으며, 시료 첨가 시의 응고시간을 용매 대조구의 응고시간으로 나눈 값으로 나타내었다.The prothrombin inhibitory effect was expressed as the average value of the experiment repeated three times or more, and the solidification time at the time of adding the sample was divided by the solidification time of the solvent control.

c). aPTT (activated Partial Thromboplastin Time) c). aPTT (activated Partial Thromboplastin Time)

혈장100μl와 다양한 농도의 시료 추출액 10㎕를 Amelung coagulometer KC-1A(Japan)의 튜브에 첨가하여 37℃에서 3분간 가온한 후, 50㎕의 aPTT reagent(Sigma, ALEXINTM)를 첨가하고 다시 37℃에서 3분간 배양하였다. 이후 50㎕ CaCl2(35mM)을 첨가한 후 혈장이 응고될 때까지의 시간을 측정하였다. 용매 대조구로는 시료 대신 DMSO를 사용하였으며, 이 경우 55.1초의 응고시간을 나타내었다. aPTT의 결과는 3회 반복한 실험의 평균치로 나타내었으며, 시료 첨가시의 응고시간을 용매 대조구의 응고시간으로 나눈 값으로 나타내었다.Add 50 μl of aPTT reagent (Sigma, ALEXIN ) to the tubes of Amelung coagulometer KC-1A (Japan) and incubate at 37 ° C for 3 minutes. For 3 minutes. Then, 50 Ca CaCl 2 (35 mM) was added and the time until the plasma was solidified was measured. As the solvent control, DMSO was used instead of the sample. In this case, the solidification time was 55.1 seconds. The results of aPTT were expressed as the average value of three replicate experiments, and the solidification time at the time of sample addition was expressed as the value divided by the solidification time of the solvent control.

samplesample Conc
(㎎/㎖)
Conc
(Mg / ml)
Anti-thrombosis activity(χ control)Anti-thrombosis activity (χ control)
TTTT PTPT aPTTaPTT

팥분말


Red bean powder
EtOH exEtOH ex 55 1.2± 0.01.2 ± 0.0 1.1± 0.01.1 ± 0.0 1.2± 0.11.2 ± 0.1
Hex frHex fr 55 1.2± 0.11.2 ± 0.1 1.0± 0.01.0 ± 0.0 1.4± 0.21.4 ± 0.2 EA fr.EA fr. 55 1.6± 0.11.6 ± 0.1 1.1± 0.11.1 ± 0.1 2.0± 0.22.0 ± 0.2 B fr.B fr. 55 1.4± 0.01.4 ± 0.0 1.1± 0.01.1 ± 0.0 1.4± 0.01.4 ± 0.0 W res.W res. 55 1.2± 0.01.2 ± 0.0 1.0± 0.11.0 ± 0.1 1.4± 0.21.4 ± 0.2


팥과립



Red bean granules
EtOH ex.EtOH ex. 55 1.1± 0.01.1 ± 0.0 1.0± 0.01.0 ± 0.0 1.3± 0.01.3 ± 0.0
Hex fr.Hex fr. 55 1.5± 0.11.5 ± 0.1 1.7± 0.11.7 ± 0.1 >15.0> 15.0 2.52.5 -- -- 0.9± 0.20.9 ± 0.2
EA fr.

EA fr.
55 2.3± 0.02.3 ± 0.0 5.0± 0.15.0 ± 0.1 >15.0> 15.0
2.52.5 1.1± 0.11.1 ± 0.1 1.1± 0.01.1 ± 0.0 2.3± 0.22.3 ± 0.2 1.251.25 1.0± 0.11.0 ± 0.1 B fr.B fr. 55 1.0± 0.01.0 ± 0.0 1.0± 0.11.0 ± 0.1 1.1± 0.11.1 ± 0.1 W res.W res. 55 1.0± 0.01.0 ± 0.0 1.0± 0.01.0 ± 0.0 1.0± 0.01.0 ± 0.0 DMSODMSO -- 1.0± 0.01.0 ± 0.0 1.0± 0.01.0 ± 0.0 1.0± 0.01.0 ± 0.0 AspirinAspirin 1.51.5 1.9± 0.01.9 ± 0.0 1.7± 0.11.7 ± 0.1 2.0± 0.02.0 ± 0.0

상기 [표 7]에 나탄 바와 같이 팥분말과는 달리 팥과립의 Hexene 및 Ethyl acetate 분획물에서 매우 강력한 내인성 혈액응고에 대한 저해활성을 확인할 수 있으며, 또 혈액응고 저해활성이 Aspirin보다 더 우수한 것을 확인할 수 있는 점을 미루어 볼 때, 본 발명에 따른 팥과립 제품은 내인성 혈액응고의 저해를 통한 항혈전 활성을 나타내어 다양한 심혈관계, 뇌혈관계 질환의 예방 및 개선에 기여할 것을 쉽게 예측할 수가 있다.As shown in Table 7, unlike the red bean powder, Hexene and Ethyl acetate fractions of red bean granules showed very strong inhibitory activity against endogenous blood coagulation, and the coagulation inhibition activity of blood was better than that of Aspirin The red bean granular product according to the present invention exhibits anti-thrombotic activity through inhibition of endogenous blood coagulation, so that it can be easily predicted to contribute to prevention and improvement of various cardiovascular and cerebrovascular diseases.

Claims (8)

a). 삶은 팥 분말 100중량부에 대하여 자일리톨 15 ~20중량부, 락토바실러스 액시도필러스, 락토바실러스 불가리쿠스, 락토바실러스 프랜타럼, 비피도박테리움 비피덤, 비피도박테리움 락티스로부터 선택되는 1종 이상의 유산균분말 10 ~ 15중량부를 혼합하여 1차 혼합물을 얻는 제1단계와,
b). 1차 혼합물 100중량부에 대하여 바나나과즙, 키위과즙 및 블루베리과즙이 중량비로 1:2:1로 혼합된 천연과즙 100 내지 150 중량부를 배합하여 2차 혼합물을 얻는 제2단계 및
c). 2차 혼합물을 과립화하여 건조하는 제3단계를 포함하는 것을 특징으로 하는 팥분말 및 천연과즙을 이용한 항혈전 활성 강화 과립형 팥분말의 제조방법.
a). The boiled bean is prepared by mixing 15 to 20 parts by weight of xylitol, 100 parts by weight of red bean powder, 1 part selected from Lactobacillus acidophilus, Lactobacillus bulgaricus, Lactobacillus frantarium, Bifidobacterium bifidum and Bifidobacterium lactis And 10 to 15 parts by weight of the lactic acid bacterium powder is mixed to obtain a first mixture,
b). A second step of blending 100 to 150 parts by weight of natural juice mixed with 1: 2: 1 by weight of banana juice, kiwifruit juice and blueberry juice in a weight ratio of 100 parts by weight of the first mixture, and
c). And a third step of granulating and drying the second mixture. The method for producing granular red bean powder having enhanced antithrombotic activity using red bean powder and natural fruit juice.
삭제delete 청구항 1에 있어서, 삶은 팥은 팥을 50 ~ 80℃에서 3 ~ 5시간 볶은 후, 물과 함께 팥을 충분히 익힌 것을 특징으로 하는 팥분말 및 천연과즙을 이용한 항혈전 활성 강화 과립형 팥분말의 제조방법.The method according to claim 1, wherein the boiled red beans are roasted at 50 to 80 ° C for 3 to 5 hours and then the red beans are sufficiently cooked with water. Way. 삭제delete 청구항 1 또는 청구항3에 기재된 제조방법에 의해 제조되는 것을 특징으로 하는 팥분말 및 천연과즙을 이용한 항혈전 활성 강화 과립형 팥분말.An antithrombotic active granular red bean powder prepared by using the red bean powder and the natural fruit juice, which is produced by the production method according to claim 1 or claim 3. 삭제delete 청구항 5 기재의 팥분말 및 천연과즙을 이용한 항혈전 활성 강화 과립형 팥분말로 이루어진 건강식품.A health food comprising granular red bean powder enhanced by antithrombotic activity using red bean powder and natural fruit juice according to claim 5. 삭제delete
KR1020140019506A 2014-02-20 2014-02-20 Enforced Antithrombosis activity, granule-type azuki bean powder containing Natural fruit juice and manufacturing Method thereof KR101590858B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020140019506A KR101590858B1 (en) 2014-02-20 2014-02-20 Enforced Antithrombosis activity, granule-type azuki bean powder containing Natural fruit juice and manufacturing Method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140019506A KR101590858B1 (en) 2014-02-20 2014-02-20 Enforced Antithrombosis activity, granule-type azuki bean powder containing Natural fruit juice and manufacturing Method thereof

Publications (2)

Publication Number Publication Date
KR20150098351A KR20150098351A (en) 2015-08-28
KR101590858B1 true KR101590858B1 (en) 2016-02-04

Family

ID=54059795

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020140019506A KR101590858B1 (en) 2014-02-20 2014-02-20 Enforced Antithrombosis activity, granule-type azuki bean powder containing Natural fruit juice and manufacturing Method thereof

Country Status (1)

Country Link
KR (1) KR101590858B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180073193A (en) 2016-12-22 2018-07-02 김해용 manufacturing method of adzuki bean powder

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101227061B1 (en) 2011-04-13 2013-02-04 박정아 The manufacturing method of red-bean powder

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101227061B1 (en) 2011-04-13 2013-02-04 박정아 The manufacturing method of red-bean powder

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180073193A (en) 2016-12-22 2018-07-02 김해용 manufacturing method of adzuki bean powder

Also Published As

Publication number Publication date
KR20150098351A (en) 2015-08-28

Similar Documents

Publication Publication Date Title
CN104663996B (en) Coffee substitute and preparation method thereof
KR20140103622A (en) The method for manufacturing functional tea product made from onion skin, and the product made by the method
KR100878876B1 (en) Process for Preparing Granule using Rubi Fructus
KR101969202B1 (en) Manufacturing method of corn bread
KR20160092631A (en) The manufacturing method of aronia powder food and the product
KR102002080B1 (en) Method for producing glutinous rice cake using persimmon, grain and medicinal plant
KR101590858B1 (en) Enforced Antithrombosis activity, granule-type azuki bean powder containing Natural fruit juice and manufacturing Method thereof
KR101708553B1 (en) Manufacturing method for red bean jello using the percolate and dried powder of phaseolus radiatus l and the red bean jello manufactured by the same
KR20150055883A (en) Soybean Paste Using Dangjo Pepper Seed and Stachys sieboldii Miq. Root and Manufacturing Method Thereof
KR102453819B1 (en) Method for manufacturing beverages using starch-containing crops
KR101837067B1 (en) A method for preparing an extract or the powder of steamed Dendropanax morbifera showing abundant total chlorophyll component and quercetin component and the health functional food comprising the an extract or the powder prepared thereby
KR20050038603A (en) Noodles, Cheonma, Noodles, Powdered Noodles, Sujebi, Dumplings, Rice Cakes, Confectionery
KR101947013B1 (en) Pudding comprising aronia, Cudrania tricuspidata and blueberry extract and preparation method thereof
KR20170107936A (en) A method for preparing an extract or the powder of non-steamed Dendropanax morbifera showing abundant total chlorophyll component and quercetin component and the health functional food comprising the an extract or the powder prepared thereby
KR20140089124A (en) Jam comprising rice grain syrup and Manufacturing method thereof
KR101559954B1 (en) Composition for Retarding Aging of Rice Cake Containing Cashew Powder
KR101164930B1 (en) Preparation method of soybean curd comprising sorghum with reinforced tannin and dietary fiber
KR101402600B1 (en) Instant noodle manufacturing methods
KR20210119221A (en) Enforced Antithrombosis activity, granule-type azuki bean powder containing Natural fruit juice and manufacturing Method thereof
KR102672335B1 (en) Functional red bean porridge having the activities of antioxidation, antidiabetes and antithrombosis comprising hempseed, beta vulgaris, walnut and almond
KR20150120038A (en) health assistance food having fermented soybeans improved flavor and manufacturing method thereof
KR101526876B1 (en) New method for producing Acanthopanax leaves extract and Acanthopanax leaves extract produced by the same method
KR102431231B1 (en) Functional rice cake comprising vitamins and method of manufacturing the same
KR20180077106A (en) A composition for improving memory or cognitive function comprising a aurantii fructus immaturus supercritical extract as an active ingredient
KR101793931B1 (en) Manufacturing Method of Improved Red Bean Doenjang

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
LAPS Lapse due to unpaid annual fee